Article
HLA-G: A New Immune Checkpoint in Cancer?
25 Jun 2020
Abstract excerpt
Human leukocyte antigen G (HLA-G), known as a central protein in providing immune tolerance to the fetus in pregnant women, is also studied for a possible role in tumor development. Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might be targets for immune checkpoint blockade in cancer immunotherapy. In order to substantiate that HLA-G is indeed an immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
